Angiogenesis
Apoptosis
Autophagy
Cell Cycle
Cytoskeletal Signaling
DNA Damage
Endocrinology&Hormones
Epigenetics
ER stress & UPR
GPCR & G Protein
Immunology&Inflammation
JAK/STAT
MAPK
Membrane Transporter/Ion Channel
Metabolic Enzyme/Protease
Metabolism
Microbiology
Natural products
Neuronal Signaling
NF-κB
PI3K/Akt/mTOR
Proteases
Protein Tyrosine Kinase
Stem Cells & Wnt
TGF-beta/Smad
Transmembrane Transporters
Ubiquitin
Others
Screening library
Peptide
Enzymes and proteins
Sphingolipids
Amino acid
Carbohydrates
Dyeing and dyes
Nucleotides
Vitamins
Analytical Standards
Drug impurity
Derivative analytical reagent
Chromatographic solvent
Analysis materials
Chiral compounds
Amino acid derivatives
Catalysts and Ligands
Benzene ring compounds
Indole compounds
Pyridine compounds
Other heterocyclic compounds
Other synthetic blocks
Inorganic salt
Proteins and Peptides
Analysis and preparation
Chiral analysis and preparation
Customized synthesis
>
Droxinostat
TL0807-5MG
In stock
76
- +
TL0807-10MG
115.4
l General Information
Product Name
General description
Droxinostat is a selective inhibitor of HDAC.
Synonym
4-(4-chloro-2-methylphenoxy)-N-hydroxybutanamide; NS 41080; NS-41080; NS41080
Purity
≥96.0%(HPLC)
CAS Number
99873-43-5
Formula
C11H14ClNO3
Molecular Weight
243.69
Suitability
BioReagent, suitable for cell culture, etc.
l Physical and Chemical Information
Appearance
White or Off-white solid
Solubility(25℃)
DMSO
≥45mg/mL
Ethanol
Water
Insoluble
l Biological Information
Biochem/Physiol Actions
Droxinostat is a selective inhibitor of HDAC, mostly for HDACs 6 and 8 with IC50 of 2.47 μM and 1.46 μM, greater than 8-fold selective against HDAC3 and no inhibition to HDAC1, 2, 4, 5, 7, 9, and 10.
l Packaging & Storage
Packaging
5mg; 10mg
Storage temp.
-20℃
l Precautions and Disclaimer
This product is for R&D use only, not for drug, household, or other uses.
l References
1. http://www.drugbank.ca
2. https://ncit.nci.nih.gov
3. https://www.ncbi.nlm.nih.gov